Literature DB >> 25603531

Immunogenicity and anti-fecundity effect of nanoparticle coated glutathione S-transferase (SjGST) DNA vaccine against murine Schistosoma japonicum infection.

Evaristus Chibunna Mbanefo1, Takashi Kumagai2, Yukinobu Kodama3, Tomoaki Kurosaki3, Rieko Furushima-Shimogawara2, Mahamoud Sama Cherif4, Shusaku Mizukami4, Mihoko Kikuchi4, Nguyen Tien Huy5, Nobuo Ohta2, Hitoshi Sasaki3, Kenji Hirayama6.   

Abstract

There is still urgent need for a vaccine against schistosomiasis, especially in Schistosoma japonicum endemic areas where even a vaccine that will interrupt zoonotic transmission will be potentially effective as an intervention tool. We had developed a novel nanoparticle gene delivery system, which has proven efficacious in gene transfection to target immune cells with complementary adjuvant effect and high protective efficacy in several diseases. Here, we applied this nanoparticle system in combination with S. japonicum glutathione S-transferase (SjGST) DNA vaccine to show the immunogenicity and anti-fecundity effect of the nanoparticle coated vaccine formulation against murine schistosomiasis. The nanoparticle-coated DNA vaccine formulation induced desired immune responses. In comparison with the nanoparticle coated empty vector, it produced significantly increased antigen-specific humoral response, T-helper 1 polarized cytokine environment, higher proportion of IFN-γ producing CD4(+) T-cells and the concomitant decrease in IL-4 producing CD4(+) T-cells. Although there was no effect on worm burden, we recorded a marked reduction in tissue egg burden. There was up to 71.3% decrease in tissue egg burden and 55% reduction in the fecundity of female adult worms. Our data showed that SjGST DNA vaccine, delivered using the nanoparticle gene delivery system, produced anti-fecundity effect on female adult schistosomes as previously described by using conventional subunit vaccine with adjuvant, proving this DNA vaccine formulation as a promising candidate for anti-pathology and transmission blocking application.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anti-fecundity; DNA vaccine; Gene delivery; Glutathione S-transferase (GST); Nanoparticle; Schistosoma japonicum

Mesh:

Substances:

Year:  2015        PMID: 25603531     DOI: 10.1016/j.parint.2015.01.005

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  6 in total

1.  Interleukin-4 Signaling Plays a Major Role in Urogenital Schistosomiasis-Associated Bladder Pathogenesis.

Authors:  Evaristus C Mbanefo; Chi-Ling Fu; Christina P Ho; Loc Le; Kenji Ishida; Olfat Hammam; Michael H Hsieh
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

2.  Combined IL-12 Plasmid and Recombinant SjGST Enhance the Protective and Anti-pathology Effect of SjGST DNA Vaccine Against Schistosoma japonicum.

Authors:  Po-Ching Cheng; Ching-Nan Lin; Shih-Yi Peng; Tsung-Fu Kang; Kin-Mu Lee
Journal:  PLoS Negl Trop Dis       Date:  2016-02-18

Review 3.  Schistosomiasis vaccines: where do we stand?

Authors:  Biniam Mathewos Tebeje; Marina Harvie; Hong You; Alex Loukas; Donald P McManus
Journal:  Parasit Vectors       Date:  2016-09-30       Impact factor: 3.876

4.  Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis.

Authors:  Gebeyaw G Mekonnen; Bemnet A Tedla; Darren Pickering; Luke Becker; Lei Wang; Bin Zhan; Maria Elena Bottazzi; Alex Loukas; Javier Sotillo; Mark S Pearson
Journal:  Vaccines (Basel)       Date:  2020-07-24

5.  Partial purification and characterization of glutathione S-transferase from the somatic tissue of Gastrothylax crumenifer (Trematoda: Digenea).

Authors:  Sakil Ahmed; Aamir Sohail; Sabiha Khatoon; Shabnam Khan; Mohammad Khalid Saifullah
Journal:  Vet World       Date:  2014-12-21

Review 6.  A Review of Nanotechnology for Targeted Anti-schistosomal Therapy.

Authors:  Tayo Alex Adekiya; Pierre P D Kondiah; Yahya E Choonara; Pradeep Kumar; Viness Pillay
Journal:  Front Bioeng Biotechnol       Date:  2020-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.